Skip to content

D&A at other companies

Rhythm Pharmaceuticals, Inc. logo
Rhythm Pharmaceuticals, Inc.RYTM
$252K-34.2%
FIP
FTAI Infrastructure Inc.FIP
$33.12M+66.8%
Lucid Group, Inc. logo
Lucid Group, Inc.LCID
$116.41M+18.8%
Origin Bancorp logo
Origin BancorpOBK
$3.78M-27.9%
Amneal Pharmaceuticals, Inc. logo
Amneal Pharmaceuticals, Inc.AMRX
$43.19M-28.2%
WillScot Holdings Corporation logo
WillScot Holdings CorporationWSC
$92.43M-4.8%

Other financials

Income statement

See full
Revenue$57.5M+6.2%
Gross profit$56.0M
Operating income$3.7M-26.0%
Net income$1.5M+1,051%
EPS (diluted)$0.07+75.0%

Balance sheet

See full
Cash & equivalents$10.1M-1.5%
Total debt$85.6M+327%
Total equity$317.4M-17.6%
Total assets$636.4M-1.5%

Cash flow

See full
Operating cash flow$10.0M+137%
CapEx$407.0K-18.8%
Free cash flow$9.6M+135%

Valuation

See full
Market cap$392.76M-34.6%
Enterprise value$468.25M-23.3%
P/E21.9×+16.6×
P/S1.8×-1.1×

Profitability

See full
Gross margin100.6%
Operating margin0.9%-3.6pp
Net margin8.3%-46.8pp
FCF margin20.2%+17.6pp

Returns & leverage

See full
Return on equity5.1%-30.3pp
Debt / equity0.3×+0.2×
Current ratio1.3×+0.2×

Where this comes from

Reported directly by i3 Verticals, Inc. in its filing.

Tagged under the XBRL concept iiiv:DepreciationDepletionAndAmortizationIncludingDiscontinuedOperations.

The official record: i3 Verticals, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about i3 Verticals, Inc.'s d&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is i3 Verticals, Inc.'s D&A?
i3 Verticals, Inc. (IIIV) reported D&A of $7.7M in Q1 2026.
How has i3 Verticals, Inc.'s D&A changed year-over-year?
i3 Verticals, Inc.'s D&A decreased by 1.7% year-over-year, from $7.84M to $7.7M.
What is the long-term trend for i3 Verticals, Inc.'s D&A?
Over 2 years (2022 to 2025), i3 Verticals, Inc.'s D&A has grown at a 0.7% compound annual growth rate (CAGR), from $29.42M to $29.84M.
What does D&A mean?
This represents the non-cash allocation of the cost of tangible and intangible assets over their estimated useful lives. It reflects the systematic reduction in the book value of assets as they are utilized in the company's operations to generate revenue.